Phase 1, Placebo-Controlled, Double-Blind, Safety Study of HBV-001 D1 in Healthy Adults.

Trial Profile

Phase 1, Placebo-Controlled, Double-Blind, Safety Study of HBV-001 D1 in Healthy Adults.

Completed
Phase of Trial: Phase I

Latest Information Update: 03 Feb 2011

At a glance

  • Drugs Aluminium hydroxide; Dengue subunit vaccine
  • Indications Dengue
  • Focus Adverse reactions
  • Sponsors Hawaii Biotech
  • Most Recent Events

    • 03 Feb 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
    • 03 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 08 Jan 2010 Preliminary results are expected in the first quarter of 2010, and results are expected by the fourth quarter of 2010, according to a Hawaii Biotech media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top